PPP1R14B | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
plasmacytoid dendritic cell	24 studies	70% ± 19%	Explore
endothelial cell	13 studies	30% ± 11%	Explore
epithelial cell	12 studies	39% ± 16%	Explore
basal cell	11 studies	35% ± 17%	Explore
fibroblast	10 studies	24% ± 6%	Explore
B cell	9 studies	25% ± 6%	Explore
conventional dendritic cell	9 studies	34% ± 19%	Explore
pericyte	9 studies	27% ± 8%	Explore
smooth muscle cell	8 studies	24% ± 9%	Explore
mast cell	7 studies	29% ± 11%	Explore
endothelial cell of vascular tree	7 studies	25% ± 6%	Explore
dendritic cell	6 studies	53% ± 28%	Explore
endothelial cell of lymphatic vessel	6 studies	32% ± 6%	Explore
abnormal cell	6 studies	44% ± 19%	Explore
macrophage	6 studies	25% ± 7%	Explore
secretory cell	6 studies	37% ± 17%	Explore
ionocyte	5 studies	30% ± 20%	Explore
natural killer cell	5 studies	21% ± 3%	Explore
CD8-positive, alpha-beta T cell	5 studies	23% ± 9%	Explore
myeloid cell	5 studies	32% ± 14%	Explore
ciliated cell	5 studies	39% ± 16%	Explore
classical monocyte	4 studies	41% ± 8%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	4 studies	28% ± 4%	Explore
CD4-positive, alpha-beta T cell	4 studies	24% ± 11%	Explore
effector memory CD8-positive, alpha-beta T cell	4 studies	23% ± 6%	Explore
hematopoietic precursor cell	4 studies	37% ± 23%	Explore
plasma cell	4 studies	36% ± 18%	Explore
connective tissue cell	4 studies	28% ± 19%	Explore
goblet cell	4 studies	27% ± 8%	Explore
pancreatic A cell	3 studies	27% ± 11%	Explore
leukocyte	3 studies	31% ± 3%	Explore
non-classical monocyte	3 studies	48% ± 14%	Explore
mononuclear phagocyte	3 studies	24% ± 6%	Explore
CD16-negative, CD56-bright natural killer cell, human	3 studies	30% ± 12%	Explore
plasmablast	3 studies	41% ± 18%	Explore
transit amplifying cell	3 studies	26% ± 5%	Explore
extravillous trophoblast	3 studies	86% ± 3%	Explore
myofibroblast cell	3 studies	20% ± 3%	Explore
neuroendocrine cell	3 studies	51% ± 27%	Explore
monocyte	3 studies	28% ± 8%	Explore
capillary endothelial cell	3 studies	24% ± 6%	Explore
endothelial cell of artery	3 studies	32% ± 8%	Explore
innate lymphoid cell	3 studies	28% ± 11%	Explore
luminal hormone-sensing cell of mammary gland	3 studies	32% ± 7%	Explore
vein endothelial cell	3 studies	28% ± 7%	Explore
neuron	3 studies	42% ± 16%	Explore
hematopoietic stem cell	3 studies	39% ± 20%	Explore
intestinal crypt stem cell	3 studies	27% ± 7%	Explore
keratinocyte	3 studies	48% ± 9%	Explore
gamma-delta T cell	3 studies	34% ± 11%	Explore
erythroblast	3 studies	30% ± 9%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	6 studies	35% ± 19%	Explore
intestine	6 studies	27% ± 13%	Explore
peripheral blood	4 studies	37% ± 12%	Explore
placenta	4 studies	38% ± 27%	Explore
pancreas	3 studies	30% ± 8%	Explore
uterus	3 studies	46% ± 14%	Explore
breast	3 studies	25% ± 4%	Explore
liver	3 studies	30% ± 6%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
pancreas	100%	3738.16	328 / 328	100%	155.16	178 / 178
esophagus	100%	3353.48	1442 / 1445	100%	167.31	183 / 183
stomach	100%	1695.58	359 / 359	100%	139.16	285 / 286
skin	100%	4893.48	1809 / 1809	100%	152.30	470 / 472
intestine	100%	1896.69	965 / 966	99%	157.19	524 / 527
kidney	100%	2478.53	89 / 89	99%	99.26	893 / 901
bladder	100%	2865.90	21 / 21	99%	233.64	498 / 504
prostate	100%	1593.91	244 / 245	99%	122.56	497 / 502
breast	100%	2173.71	459 / 459	98%	154.71	1101 / 1118
lung	99%	1994.50	573 / 578	99%	182.58	1146 / 1155
uterus	98%	1476.21	166 / 170	100%	245.08	459 / 459
thymus	99%	1675.64	647 / 653	98%	103.06	592 / 605
ovary	94%	1128.46	170 / 180	100%	283.65	430 / 430
liver	100%	2179.52	226 / 226	94%	94.42	383 / 406
adrenal gland	100%	2921.43	258 / 258	86%	60.95	197 / 230
brain	87%	871.11	2286 / 2642	98%	134.88	694 / 705
eye	0%	0	0 / 0	100%	122.64	80 / 80
lymph node	0%	0	0 / 0	100%	182.36	29 / 29
spleen	100%	2472.21	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	206.38	45 / 45
ureter	0%	0	0 / 0	100%	513.59	1 / 1
adipose	100%	2493.43	1203 / 1204	0%	0	0 / 0
muscle	100%	3757.88	802 / 803	0%	0	0 / 0
blood vessel	100%	3005.34	1330 / 1335	0%	0	0 / 0
heart	98%	2126.01	847 / 861	0%	0	0 / 0
peripheral blood	54%	1206.05	501 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0042325	Biological process	regulation of phosphorylation
GO_0045087	Biological process	innate immune response
GO_0005737	Cellular component	cytoplasm
GO_0004865	Molecular function	protein serine/threonine phosphatase inhibitor activity

IV. Literature review

[source]

Gene name	PPP1R14B
Protein name	Protein phosphatase 1 regulatory subunit 14B (Phospholipase C-beta-3 neighbouring gene protein) Protein phosphatase 1 regulatory subunit 14
Synonyms	PLCB3N PNG
Description	FUNCTION: Inhibitor of PPP1CA. Has over 50-fold higher inhibitory activity when phosphorylated (By similarity). . FUNCTION: Inhibitor of PPP1CA. . FUNCTION: Inhibitor of PPP1CA. .
Accessions	F5GXC4 F5H2U0 ENST00000309318.8 Q96C90 ENST00000392210.6 ENST00000542235.1

PPP1R14B report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review